Invex Therapeutics Ltd.ASX: IXC

First Patient Randomised in IIH EVOLVE Phase III Trial

Nov 21, 2022 at 2:39 AM UTC · Issued by Invex Therapeutics Ltd.

Invex Therapeutics Ltd has released a press release.

View Attachment